|
Volumn 12, Issue 5, 2014, Pages 643-648
|
International adaptations of NCCN clinical practice guidelines in oncology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
FLUOROURACIL;
ARTICLE;
CANCER DIAGNOSIS;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER THERAPY;
COLORECTAL CANCER;
CONSENSUS;
DRUG APPROVAL;
EVIDENCE BASED PRACTICE;
GEOGRAPHY;
GROSS NATIONAL PRODUCT;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE DISPARITY;
HEALTH CARE QUALITY;
HUMAN;
ONCOLOGY;
PHARMACOGENETICS;
PRACTICE GUIDELINE;
RESOURCE ALLOCATION;
SOUTH AND CENTRAL AMERICA;
TELECONFERENCE;
UNITED STATES;
HEALTH;
NEOPLASM;
GLOBAL HEALTH;
HUMANS;
NEOPLASMS;
PRACTICE GUIDELINES AS TOPIC;
UNITED STATES;
|
EID: 84900432125
PISSN: 15401405
EISSN: 15401413
Source Type: Journal
DOI: 10.6004/jnccn.2014.0068 Document Type: Article |
Times cited : (36)
|
References (8)
|